Matthew W Johnson1, Evan S Herrmann2,3, Mary M Sweeney2, Robert S LeComte2, Patrick S Johnson2,4. 1. Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD, 21224, USA. mwj@jhu.edu. 2. Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD, 21224, USA. 3. Columbia College of Physicians and Surgeons, New York State Psychiatric Institute, New York, NY, USA. 4. Department of Psychology, California State University, Chico, CA, USA.
Abstract
OBJECTIVES: Although cocaine use has been linked to sexual HIV risk behavior for decades, the direct effects of cocaine on sexual desire and sexual decision-making are unexamined. Research suggests delay discounting (devaluation of future outcomes) and probability discounting (devaluation of uncertain outcomes) play roles in condom use decisions. This study examined the effect of cocaine administration on sexual desire, hypothetical condom use, and discounting tasks. METHODS: This double-blind, within-subjects study compared the effects of 0, 125, and 250 mg/70 kg oral cocaine HCl in 12 cocaine users. Measures included sexual desire and other subjective ratings, the Sexual Delay Discounting Task, the Sexual Probability Discounting Task, and monetary delay and probability discounting tasks. RESULTS:Cocaine caused dose-related increases in sexual desire and prototypical stimulant abuse-liability ratings. Relative to placebo, cocaine did not significantly alter condom use likelihood when condoms were immediately available or when sex was associated with 100% certainty of sexually transmitted infection (STI). In contrast, cocaine dose-dependently strengthened the effect of delay (sexual delay discounting) and STI uncertainty (sexual probability discounting) in decreasing condom use likelihood. Cocaine caused no significant change in monetary delay and probability discounting. CONCLUSION: This is the first study showing that cocaine administration increases sexual desire. Detrimental effects of cocaine on sexual risk were only observed when safer sex required delay, or STI risk was uncertain (representative of many real-world scenarios), suggesting a critical role of discounting processes. Lack of monetary effects highlights the importance of studying clinically relevant outcomes when examining drug effects on behavioral processes.
RCT Entities:
OBJECTIVES: Although cocaine use has been linked to sexual HIV risk behavior for decades, the direct effects of cocaine on sexual desire and sexual decision-making are unexamined. Research suggests delay discounting (devaluation of future outcomes) and probability discounting (devaluation of uncertain outcomes) play roles in condom use decisions. This study examined the effect of cocaine administration on sexual desire, hypothetical condom use, and discounting tasks. METHODS: This double-blind, within-subjects study compared the effects of 0, 125, and 250 mg/70 kg oral cocaine HCl in 12 cocaine users. Measures included sexual desire and other subjective ratings, the Sexual Delay Discounting Task, the Sexual Probability Discounting Task, and monetary delay and probability discounting tasks. RESULTS:Cocaine caused dose-related increases in sexual desire and prototypical stimulant abuse-liability ratings. Relative to placebo, cocaine did not significantly alter condom use likelihood when condoms were immediately available or when sex was associated with 100% certainty of sexually transmitted infection (STI). In contrast, cocaine dose-dependently strengthened the effect of delay (sexual delay discounting) and STI uncertainty (sexual probability discounting) in decreasing condom use likelihood. Cocaine caused no significant change in monetary delay and probability discounting. CONCLUSION: This is the first study showing that cocaine administration increases sexual desire. Detrimental effects of cocaine on sexual risk were only observed when safer sex required delay, or STI risk was uncertain (representative of many real-world scenarios), suggesting a critical role of discounting processes. Lack of monetary effects highlights the importance of studying clinically relevant outcomes when examining drug effects on behavioral processes.
Entities:
Keywords:
Cocaine; Delay discounting; HIV; Humans; Sexual desire; Sexual risk behavior
Authors: Nora D Volkow; Gene-Jack Wang; Joanna S Fowler; Frank Telang; Millard Jayne; Christopher Wong Journal: Am J Psychiatry Date: 2007-01 Impact factor: 18.112
Authors: H Jonathon Rendina; Raymond L Moody; Ana Ventuneac; Christian Grov; Jeffrey T Parsons Journal: Drug Alcohol Depend Date: 2015-07-09 Impact factor: 4.492
Authors: Jennifer L Perry; Erin B Larson; Jonathan P German; Gregory J Madden; Marilyn E Carroll Journal: Psychopharmacology (Berl) Date: 2004-08-27 Impact factor: 4.530
Authors: Evan S Herrmann; Dennis J Hand; Matthew W Johnson; Gary J Badger; Sarah H Heil Journal: Drug Alcohol Depend Date: 2014-07-30 Impact factor: 4.492
Authors: Ryan P Bell; Sheri L Towe; Zahra Lalee; Scott A Huettel; Christina S Meade Journal: Cogn Affect Behav Neurosci Date: 2020-08 Impact factor: 3.282
Authors: Mary M Sweeney; Meredith S Berry; Patrick S Johnson; Evan S Herrmann; Steven E Meredith; Matthew W Johnson Journal: Psychol Health Date: 2019-07-16
Authors: Jeb Jones; Jodie L Guest; Patrick S Sullivan; Michael R Kramer; Samuel M Jenness; Jessica M Sales Journal: Sex Health Date: 2018-06 Impact factor: 2.706